Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The Food and Drug Administration (FDA) classifies BPC-157 strictly as a research compound, prohibiting the product's use as an approved therapeutic or dietary supplement in human applications
One document warns that a peptide, MOTS-c, marketed online to promote the metabolism of fatty acids in the liver, insulin resistance and weight loss, hasnt been proven safe for human use in compounded drugs
For intranasal administration, commonly reported empirical dosing includes 100-200 mcg per nostril taken once or twice daily (obviously, BPC-157 should first be reconstituted in bacteriostatic water at an appropriate concentration for nasal delivery)
The British Journal of Haematology state: The use of high dose oral cyanocobalamin is licenced for use in several countries.however the efficacy and cost-effectivenessis yet to be established. And I am stating: Vital treatment should not be restricted or stopped
Wiener Medizinische Wochenschrift (2015) 165(1):39
Clear standards, local context, and zero fluff, because hormones are serious business and so is your time
US$ 20.57
US$ 23.09
US$ 27.69
US$ 20.45
US$ 28.23
US$ 24.22
US$ 26.29
US$ 20.80
US$ 29.61
